Reply to: “On the Distinction Between Prognostic and Predictive Inference in Multicancer Early Detection” and “Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution”
JCO Precision Oncology · 2026-06 · 10 (6)
DOI: 10.1200/po-26-00523 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2026-06. Verfasst von Charles Swanton. Beteiligte Einrichtung: Charles Swanton, PhD, MBBS, Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Charles Swanton, PhD, MBBS, Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.
ORCID-Profile: Charles Swanton
Zitieren
APA
Swanton, C. (2026). Reply to: “On the Distinction Between Prognostic and Predictive Inference in Multicancer Early Detection” and “Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution”. JCO Precision Oncology, 10(6). https://doi.org/10.1200/po-26-00523
Vancouver
Swanton C. Reply to: “On the Distinction Between Prognostic and Predictive Inference in Multicancer Early Detection” and “Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution”. JCO Precision Oncology. 2026;10(6). doi:10.1200/po-26-00523
BibTeX
@article{Swanton2026,
author = {Swanton, Charles},
title = {Reply to: “On the Distinction Between Prognostic and Predictive Inference in Multicancer Early Detection” and “Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution”},
journal = {JCO Precision Oncology},
year = {2026},
volume = {10},
number = {6},
doi = {10.1200/po-26-00523}
}
EUVIMED